Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

Conditions: Primary Open Angle Glaucoma; Ocular Hypertension Interventions: Drug: DE-126 Ophthalmic Solution 0.002% QD; Drug: Timolol Maleate Ophthalmic Solution 0.5% BID Sponsor: Santen Inc. Recruiting

http://www.clinicaltrials.gov/ct2/show/NCT04742283?lupd_s=01%2F09%2F2021&lup...

Source: ClinicalTrials.gov - February 8, 2021 Category: Research Source Type: clinical trials